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Abstract
One of the best studied read-outs of epigenetic change is the differential expression of imprinted genes, controlled by
differential methylation of imprinted control regions (ICRs). To address the impact of genotype on the epigenome, we
performed a detailed study in 128 pairs of monozygotic (MZ) and 128 pairs of dizygotic (DZ) twins, interrogating the DNA
methylation status of the ICRs of IGF2, H19, KCNQ1, GNAS and the non-imprinted gene RUNX1. While we found a similar
overall pattern of methylation between MZ and DZ twins, we also observed a high degree of variability in individual CpG
methylation levels, notably at the H19/IGF2 loci. A degree of methylation plasticity independent of the genome sequence
was observed, with both local and regional CpG methylation changes, discordant between MZ and DZ individual pairs.
However, concordant gains or losses of methylation, within individual twin pairs were more common in MZ than DZ twin
pairs, indicating that de novo and/or maintenance methylation is influenced by the underlying DNA sequence. Specifically,
for the first time we showed that the rs10732516 [A] polymorphism, located in a critical CTCF binding site in the H19 ICR
locus, is strongly associated with increased hypermethylation of specific CpG sites in the maternal H19 allele. Together, our
results highlight the impact of the genome on the epigenome and demonstrate that while DNA methylation states are
tightly maintained between genetically identical and related individuals, there remains considerable epigenetic variation
that may contribute to disease susceptibility.
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Introduction
Genetic polymorphisms are heritable alterations in the DNA
sequence and contribute to phenotypic variation, and sometimes
to disease susceptibility, through effects on gene expression and
function. Twin studies however, demonstrate that genetic
polymorphisms alone are often insufficient to cause phenotypic
variance and disease susceptibility, and other factors are
required, including possible epigenetic factors. In contrast to
genetic alterations, an epigenetic alteration is defined as a
heritable change in gene expression that does not involve a
change in the DNA sequence. Epigenetic mechanisms play an
essential role in eukaryotic gene regulation by changes in DNA
methylation and modification of chromatin structure, which in
turn modulate gene expression. However, how the sequence of
the genome and single nucleotide polymorphisms (SNPs) may
impact on the epigenome, in particular in modulating regional
specific DNA methylation and gene expression patterns is still
largely unknown.
Imprinted genes are transcribed from only one of the parental
chromosomes. To date, about 80 imprinted genes have been
identified in mammals that display parental specific expression.
Although dispersed throughout the genome, imprinted genes are
often found in clusters, which are regulated via a central control
element, also known as imprinting control region (ICR). The
epigenetic state of an ICR, and in particular the DNA methylation
level has been shown to be crucial for maintaining the imprinted
state of the genes in a cluster [1]. As the control regions display
allele specific DNA methylation they are also referred to as
differentially methylated regions (DMRs). The best documented
imprinting cluster harbours the genes IGF2 and H19, and is
located on chromosome 11p15.5 in humans (Figure 1A) [2]. These
adjacent genes are reciprocally imprinted; the potential growth
factor IGF2 is paternally expressed, whereas for the noncoding
RNA H19, the maternal allele is active [3,4]. Extensive evidence
shows the imprinting status of the IGF2/H19 locus is regulated by
an ICR upstream of H19 [5] that displays parent-of-origin-
dependent (paternal) methylation and contains binding sites for the
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zinc-finger CCCTC-binding factor, known as CTCF. Other
elements within the IGF2/H19 locus have also been reported to be
involved in the regulatory mechanism of the region [6,7,8].
Importantly, the methylation status of one of these elements (IGF2-
DMR; located in the last exon of IGF2 and normally only
methylated on the paternal allele) has been reported to be
associated with the risk of developing human colorectal cancer in
some studies [9] but not in others [10]. A second imprinting
domain is located centromeric to the IGF2/H19 locus, referred to
as KCNQ1 (Figure 1A). This domain contains several maternally
expressed genes and a single paternally expressed transcript,
KCNQ1OT1. The promoter of KCNQ1OT1 is contained within
intron 10 of the KCNQ1 gene and harbours the imprinting control
region KvDMR. KvDMR is methylated on the maternal allele
and has been implicated in the manifestation of parent-of-origin-
specific expression of the genes in the locus. Moreover, disruption
of the differential methylation of KvDMR is observed in over half
of the cases of the congenital overgrowth disorder called Beckwith-
Wiedemann syndrome (BWS) [11,12,13], as well as in colorectal
cancer tissue specimens [14]. Another example of clustering of
imprinted genes in the human genome is the GNAS locus on
20q13.32. GNAS is a complex locus, which gives rise to
alternatively spliced isoforms that show maternal-, paternal- and
biallelic expression as well as a noncoding antisense transcript
(Figure 1B) [15]. The principal control region NESPAS-ICR is
methylated on the maternal allele and contains the promoter for
the antisense transcript [16]. Disruption of the (regulation of the)
GNAS locus can result in various human disorders, including
pseudohypoparathyroidism and some tumours of different origin
[17].
It is now well accepted that the DNA methylation status of
imprinting control regions plays a critical role in the regulation of
imprinted genes. However, it is still poorly understood how
variable the DNA methylation levels at these functionally
important regions are between individuals. In addition, it is not
known to what extent the epigenome is influenced by an
individual’s genome sequence, whether DNA methylation vari-
ability is restricted to localised regions or if the variability is more
generally regulated across chromosomes. To answer these
questions, we examined in detail the DNA methylation status of
four imprinting control regions (H19-ICR, IGF2-DMR, KvDMR
and NEPAS-ICR) located both in clusters and on different
chromosomes in a sample of 128 pairs of monozygotic and 128
pairs of dizygotic twins, to address potential in cis (at localised
regions) and/or in trans (between regions or across chromosomes)
methylation variance in identical and related individuals. We also
included a DNA methylation analysis of the RUNX1 promoter, a
biallelically expressed gene that has shown evidence of sporadic
methylation in normal peripheral blood cells [18] to gauge the
level of variation relative to variation at imprinted loci (Figure 1C).
Finally, ten SNPs within the IGF2/H19 locus were examined to
investigate any potential link between genotype and epigenotype
(Figure 1A).
We show that DNA methylation levels at critically important
imprinted regions differed considerably, even within identical twin
pairs. The variation is typically confined to localised regions, and
occurs randomly between the regions. Importantly, we propose
that this variability allows for possible phenotypic diversity and
variability in disease susceptibility. Interestingly, there appears to
be a genetic contribution to the DNA methylation level at the H19
imprinting control region. Here, we find that a single nucleotide
polymorphism appears to have substantial impact on the DNA
methylation status of the region, but only if inherited on the
maternal allele. We speculate that this polymorphism may directly




The twins analysed are part of a study on moliness and cognitive
function [19,20,21] and comprised 512 adolescent twins (70
female and 58 male monozygotic twin pairs; 25 female, 29 male
and 74 opposite sex dizygotic twin pairs), with a mean age of 14.15
years (SD=2.46; range 12–22.85). The samples are predominant-
ly (.95%) of northern European origin (mainly Anglo-Celtic).
Zygosity of the twins was confirmed using microsatellite repeat
marker testing. All cases and controls gave informed consent to
participation in this study, and the study protocol was approved by
the Queensland Institute of Medical Research Human Research
Ethics Committee, (Ethics approvals P193 and P455).
DNA methylation assay design
MassCleave assays against the genomic regions of interest were
designed and tested using the AmpliconReport R-script we described
previously [22]. The analysed regions encompassed the imprinted
regions H19-ICR [23], IGF2-DMR [9], KvDMR [13,14] and
NESPAS-ICR [16], and the promoter of the non-imprinted
RUNX1 gene (Figure S1).
Genomic bisulphite treatment
DNA methylation measurements were performed on genomic
DNA extracted from whole blood. Bisulphite treatment was
carried out using the EZ-96 DNA Methylation-Gold Kit (Zymo
Research: Cat No. D5008) according to the manufacturer’s
instructions. In brief, 500 ng DNA was used in the bisulphite
reaction and incubated for 8 hours at 55uC. After desulfonation
and clean up, the bisulphite treated DNA was resuspended in
50 ml of which 2 ml was used in each PCR.
PCR-tagging, in vitro transcription and mass
spectrometry analysis
The target regions were amplified in triplicate using the primer
pairs and annealing temperatures (Ta) described in Table S1. The
MassCleave methylation analysis was performed as described
previously [22]. In brief, the PCR reactions were carried out in a
total volume of 5 ml using 200 nM forward and reverse primer,
200 mM dNTPs, 1.5 mM MgCl2 1:100,000 dilution of SYBR
Green (Invitrogen) and 0.35 U Platinum Taq DNA polymerase
(Invitrogen) in 16 PCR buffer without magnesium. PCR success
was determined via melt curve analysis (ABI PRISMH 7700).
Unincorporated dNTPs were dephosphorylated by incubation at
37uC for 20 min in the presence of 1.7 ml H2O and 0.3 U Shrimp
Alkaline Phosphatase (SAP), followed by a heat-inactivation for
5 min at 85uC. The triplicate PCR samples after SAP-treatment
were pooled and of this pool, two microliters were used in a 7 ml
transcription reaction, containing 3.14 mM DTT, 2.5 mM dCTP,
1 mM rUTP, 1 mM rGTP, 1 mM rATP, 20 U T7 R&DNA
polymerase and 0.09 mg/ml RNase A in 0.646 T7 polymerase
buffer (all reagents from SEQUENOM, San Diego). Transcription
and digestion were performed in the same step at 37uC for
3 hours. After the addition of 20 ml H2O, conditioning of the
phosphate backbone prior to MALDI-TOF MS was achieved by
the addition of 6 mg CLEAN Resin (SEQUENOM, San Diego).
Twenty-two nanoliters of the cleavage reactions were robotically
dispensed onto silicon chips preloaded with matrix (Spectro-
CHIPs; SEQUENOM, San Diego). Mass spectra were collected
using a MassARRAY mass spectrometer (SEQUENOM).
Impact of the Genome on the Epigenome Twin Study
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Calculation of methylation ratios
Calculation of the DNA methylation levels was performed using
the R-script Analyze Sequenom Function (ASF) which we described
previously [22]. All statistical calculations were carried out using
either Stata 9 (StataCorp LP, Texas, USA) or the free ‘R’ software
package for statistical computing (http://www.R-project.org).
Clonal analysis of DNA methylation status
For clonal analysis, three independent PCR reactions were
performed and products pooled to ensure a representative
methylation profile. PCR products were purified using the Wizard
PCR DNA purification system and cloned into the pGEM-T-Easy
Vector (Promega) using the Rapid Ligation Buffer System
(Promega). Individual clones were purified and sequenced and
the methylation status for each CpG site was determined.
Genotyping
The SNPs rs217727, rs2839701, rs2585, rs680, rs734351,
rs3213223, rs3213221, rs3741212 and rs1004446 residing in the
IGF2/H19 locus were genotyped in multiplex assays designed
Figure 1. Genomic regions interrogated. Four imprinted regions were tested for their DNA methylation levels: (A) three are located in close
proximity of each other on 11p15.5: H19-ICR, IGF2-DMR and KvDMR, and (B) one is located on 20q13.32: NESPAS-ICR. (C) As a non-imprinted region
the RUNX1 promoter was interrogated. Features on the (+) and (2) strand are shown to the right or left of the line, respectively. The imprinting status
of the genes is shown in pink (maternally expressed), blue (paternally expressed), and white (biallelic expression or imprinted expression not known).
Intronic regions are indicated as dotted lines. Imprinting control regions and differentially methylated regions (ICR and DMR, respectively) are marked
by circles coloured according to the parental origin of the imprint (tel: telomeric end; cen: centromeric end [adapted from 2,43]). Single nucleotide
polymorphisms interrogated in this study are also indicated on 11p15.5.
doi:10.1371/journal.pone.0025590.g001
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using the Sequenom MassARRAY Assay Design software (version
3.0). SNPs were typed using Sequenom iPLEX chemistry on a
MALDI-TOF Compact Mass Spectrometer (SEQUENOM). The
2.5 ml PCR reactions were performed in standard 384-well plates
using 12.5 ng genomic DNA, 0.8 unit of Taq polymerase
(HotStarTaq; QIAGEN, Australia), 500 mmol of each dNTP,
1.625 mM of MgCl2, and 100 nmol of each PCR primers
(Bioneer, Korea). Standard PCR thermal cycling conditions and
post-PCR extension reactions were carried out as described
previously [24]. The iPLEX reaction products were desalted by
diluting samples with 15 ml of water and adding 3 mg of resin. The
products were spotted on a SpectroChip (SEQUENOM), and data
were processed and analyzed by MassARRAY TYPER 3.4
software (SEQUENOM). The rs10732516 and rs45596642
genotypes were determined from the MassARRAY methylation
analyses profiles as described previously [22].
Statistical analysis
The quantitative methylation of each CpG unit measured by
the MALDI-TOF-MS assay was filtered to exclude poor-quality
data. Only CpG units with values in at least 75% of the 512
samples were selected. The results for the CpG unit harbouring
the rs10732516 SNP in the H19-ICR were removed from the
DNA methylation analysis as this polymorphism affected the
methylation call in the assay. This resulted in the analysis of 83
CpG sites divided over 54 CpG units and originating from five
regions in the genome. Correlations between the methylation
levels of different CpG sites were calculated using the nonpara-
metric Spearman correlation test (two-tailed, P-value,0.05). The
non-parametric Kruskal-Wallis test, followed by a Dunn’s multiple
comparison test was used to determine whether a statistically
significant difference was observed between the discordance levels
in MZ, DZ and non-related individuals. The group of non-related
individuals was created by randomly mixing MZ or DZ
individuals that were not of the same family within at least two
generations. Significant differences between MZ and DZ twins in
the presence of (concordant) loss or gain of methylation (LOM or
GOM, respectively) were tested using the chi square test.
CTCF binding analysis
Publically available ChIP-seq data from the ENCODEChromatin
Group at the Broad Institute [25] was downloaded for all available
normal cell lines (HMEC [humanmammary epithelial cells], HSMM
[normal human skeletal muscle myoblasts], HUVEC [human
umbilical vein endothelial cells], NHEK [normal human epidermal
keratinocytes], NHLF [normal human lung fibroblasts] and the H1
human embryonic stem cell line). The Position Weight Matrix
(PWM) for the CTCF binding sequence was obtained from the
JASPAR database [26]. Mean enrichment scores near all sequences
that matched the PWM with at least 80% sequence match were
calculated on all autosomes and the X chromosome in all 6 cell lines
(2500 to +500 bp relative to the CTCF binding site; n=52,588
sites). Next, the cytosine at position 6 of the PWM for CTCF was
replaced with a thymidine and the mean enrichment score was
calculated again (n=32,334 sites). To account for differences in the
number of reads between samples, the comparison of mean
enrichment scores was performed directly within each cell line.
Results
DNA methylation variance at H19-ICR, IGF2-DMR, KvDMR,
NESPAS-ICR and the RUNX1 promoter in MZ and DZ twins
We performed a detailed DNA methylation analysis of four
imprinted control regions (ICRs: H19-ICR, IGF2-DMR, KvDMR
Figure 2. DNA methylation levels at four imprinted loci and the RUNX1 promoter in MZ and DZ twins. Box plot results of the DNA
methylation levels are shown per CpG unit as determined by MALDI-TOF mass spectrometry. Each box plot shows the distribution of DNA
methylation in 256 monozygotic (MZ) or dizygotic (DZ) individuals (left or right panel, respectively; brown: H19-ICR; green: IGF2-DMR; blue: KvDMR;
pink: NESPAS-ICR; orange: RUNX1).
doi:10.1371/journal.pone.0025590.g002
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and NESPAS-ICR) and of the RUNX1/AML1 promoter interro-
gating 14, 8, 15, 17 & 29 CpG sites respectively (Figure S1) from
whole blood DNA from 256 pairs of adolescent twins. We found
that MZ and DZ individuals have remarkably similar DNA
methylation levels and as expected, the median methylation levels
of the imprinted regions were around 50% with some exceptions
for individual CpG units that displayed elevated levels (Figure 2).
In contrast, the RUNX1 promoter only contained low levels of
DNA methylation with median levels ranging from 0% to 18%
(Figure 2). Notably, for both the MZ and DZ pairs we found that
H19-ICR and IGF2-DMR DNA methylation levels displayed a
considerable degree of variation, far greater than KvDMR,
NESPAS-ICR or the RUNX1 promoter (average interquartile
ranges for H19-ICR, IGF2-DMR, NESPAS-ICR, KvDMR and
RUNX1 are 0.12, 0.12, 0.05, 0.05 and 0.06, respectively).
To investigate the relationship between DNA methylation levels
at different CpG units measured within an individual, we
performed a nonparametric Spearman correlation test and plotted
the results in a correlation matrix (Figure 3). Significant correlation
scores were obtained for all correlation coefficients above +0.23
(two-tailed, P-value,0.0001). As can be clearly seen in Figure 3,
the methylation levels within each ICR/DMR are highly
correlated. Especially in H19-ICR, KvDMR and NESPAS-ICR
strong correlation coefficients were observed (up to 0.84 in
KvDMR). In contrast, the RUNX1 promoter displays more
sporadic and random DNA methylation. The correlation between
different ICRs was much lower. Only between KvDMR and
NESPAS-ICR a modest, but significant correlation was observed
even though these regions are located in different chromosomes
(11p15.5 and 20q13.32, respectively). Together, these results
demonstrate a considerable degree of variation in the DNA
methylation levels at critical regulatory regions in the genome of
healthy MZ and DZ twins. In contrast, within an individual, the
DNA methylation level at specific CpG sites is highly dependent
on the methylation levels of neighbouring sites.
Intra-twin discordance in DNA methylation profiles
Next, we investigated the differences in DNA methylation within
MZ twin pairs, DZ twin pairs and between non-related individuals to
determine if specific loci show discordant methylation between
individuals. As DNAmethylation levels displayed strong correlations
within each region, we averaged the methylation differences per
interrogated region (Figure 4; results for individual CpG units can be
found as Figures S2, S3, S4, S5, S6). Statistical analysis (Kruskal-
Wallis one-way analysis of variance test and a post hoc Dunn’s test)
revealed significant differences between MZ and DZ methylation
discordance for H19-ICR and RUNX1 (P-values,0.05). In H19-
ICR, genetically identical individuals (MZ twins) displayed signifi-
cantly less methylation discordance than DZ pairs, or non-related
individuals suggesting the local genetic sequence may be influencing
Figure 3. Correlation matrix of DNA methylation levels between all CpG units. The nonparametric Spearman correlation scores between
the DNA methylation levels of different CpG units are displayed in a 2D matrix in shades of blue and yellow (for positive and negative values,
respectively). All correlation scores above 0.23 are significant (two-tailed, P-value,0.0001).
doi:10.1371/journal.pone.0025590.g003
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the methylation status at the H19-ICR. For the RUNX1 promoter
the discordance in DNAmethylation was also less in MZ or DZ twin
pairs compared to non-related individuals. The other interrogated
regions did not reveal significant differences in intra-twin discor-
dances, implicating either a lack of genetic or environmental
pressure on the DNA methylation levels at these imprinted regions.
Gain or loss of localised and regional DNA methylation
Changes in DNA methylation at imprinting control loci or other
critical regions in the genome have been clearly associated with
many diseases and disease susceptibilities [9,11,12,13,14,17,23,
27,28,29]. We therefore investigated the frequency of gain or loss of
methylation (GOM or LOM, respectively) in the cohort of
adolescent twins, where GOM or LOM calls were determined by
10% deviation from the median DNA methylation levels (Table 1
and Table S2). In addition, we determined whether only one or
both individuals of a twin pair displayed the same GOM or LOM,
that is were they concordant or discordant in gain or loss of
methylation. Interestingly, in most cases LOM or GOM was found
to be discordant as only one of the individuals of a twin pair
displayed a change, even in MZ twin pairs (Table 1). Still, we
observed significantly more MZ than DZ twin pairs with
concordant LOM in H19-ICR (60 vs. 38; chi-square test,
P,0.01). Likewise, in NESPAS-ICR 22 MZ twins displayed a
concordant LOM, whereas no DZ twin pairs showed loss of
methylation (chi-square test, P,0.001). KvDMR was the only locus
that showed discordance for LOM more frequently in MZ twins
compared to DZ twins (52 vs. 20; chi-square test, P,0.001).
Examples of types of variance in DNA methylation levels within
individual MZ twin pairs, are shown in Figure 5 including localised
concordance: both individuals of a twin pair displayed losses or gains in
DNAmethylation in a similar fashion over localised regions, localised
discordance: only one individual of a twin pair displayed losses or gains
in DNA methylation in a discordant fashion over localised regions,
regional concordance or discordance: consistent LOM or GOM across a
contiguous region, and concordance or discordance across chromosomes
(trans). In conclusion, aberrations in the fine control of DNA
methylation levels in imprinted regions are common in MZ and DZ
twins and typically concordant and discordant changes occur at
local, regional and across chromosomes.
Influence of genotype on DNA methylation
As shown in Figure 4, the DNA methylation levels in H19-ICR
displayed increased similarity when two individuals were more
similar at the genetic level (MZ versus DZ twins versus non-related
individuals). To further test any influence of genotype on DNA
Figure 4. Gene-level analysis of intra-twin discordance in DNA methylation. The discordance in DNA methylation levels was calculated
within monozygotic twin pairs, dizygotic twin pairs and between non-related individuals (MZ, DZ and NR, respectively). The methylation differences
between individuals were summed over a region and displayed as scatter plots with a horizontal black line representing the group median (see
Figures S2, S3, S4, S5, S6 for intra-twin comparisons at each individual CpG unit). Significant differences between groups were identified using the
non-parametric Kruskal-Wallis test, followed by a Dunn’s multiple comparison test. In H19-ICR, the methylation discordance was significantly less in
MZ twin pairs than in DZ pairs, or between non-related individuals. Within the RUNX1 promoter, the non-related individuals displayed the greatest
discordance over MZ or DZ twin pairs (*: P-value,0.05; **: P-value,0.01; ***: P-value,0.001).
doi:10.1371/journal.pone.0025590.g004
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methylation levels, we performed a genotype analysis of a number
of single nucleotide polymorphisms (SNPs) in the H19/IGF2 locus
(Figure 1A). For one SNP, rs10732516, we were also able to
determine allele-specific methylation (Figure S7) [22]. To our
surprise, we found that the maternal rs10732516 [A] allele
(normally the unmethylated allele in this region), was methylated
to greater levels over the entire H19-ICR region and most
significantly at CpG sites 2, 3 and 4 (Figure 6A; Kruskal-Wallis test
with post-hoc a Dunn’s test; P,0.05). A similar propensity to show
hypermethylation was not observed for the maternal rs10732516
[G] allele. Both MZ and DZ individuals displayed a more
hypermethylated state in the maternal rs10732516 [A] allele and
further investigation of the rs10732516 genotype could fully
explain the intra-individual discordance observed in Figure 4
(Kruskal-Wallis test per genotype with post-hoc a Dunn’s test was
not significant; P.0.05). From the analysis of the other SNPs in
the vicinity it became apparent that rs10732516 and rs2839701
are co-inherited as they are part of the same haplotype block; the
presence of an rs2839701 [G] allele also marks a hypermethylated
state of the H19-ICR locus (Figure 6B). As we cannot distinguish
the parental origin of the rs2839701 polymorphism, the
heterozygote [CG/GC] (=R) group displayed a larger variance
in DNA methylation compared to [CC] or [GG] homozygotes.
Other SNPs however that were tested within the H19/IGF2 locus
on 11p15.5 did not correlate with any differential DNA
methylation levels for the CpG sites tested (data not shown). We
confirmed the increase in methylation of CpG sites at the 59 end of
the H19-ICR, using clonal bisulphite sequencing reactions for
each genotype (Figure 7). In the rs10732516 [AA] and [GA] (=R)
genotypes, the maternal alleles displayed elevated methylation
levels compared to the [AG] and [GG] genotypes (44% and 33%
versus 16% and 20% DNA methylation, respectively).
Notably, the rs10732516 polymorphism directly overlaps with
the 6th CTCF binding site within this region (Figure 7, 8A),
providing a possible mechanistic link between the nature of the
SNP and the preponderance for methylation. When comparing
the CTCF binding strengths at the various CTCF binding sites in
the region in normal cell lines (ENCODE ChIP-seq data from the
Chromatin Group at Broad Institute) [25] we noted the results for
the fifth CTCF binding site are markedly reduced compared to the
other binding sites in the region (Figure 8B). The sequence of the
fifth CTCF site is 100% identical to the binding site containing the
rs10732516 [A] polymorphism (Figure 8A). Furthermore, ge-
nome-wide analyses of the binding strength at locations where
either a cytosine or thymidine is present at position 6 of the
consensus CTCF sequence also revealed a drastic reduction of
CTCF enrichment scores in case of a thymidine at this position
(Figure 8C and Figure S8). This data suggests that in the H19-ICR
region, the genotype of the underlying sequence (in particular the
rs10732516 polymorphism) may have a substantial impact on the
determination of the DNA methylation status of the locus.
Discussion
Over the past decades, the importance of studies on monozygotic
twins has become increasingly apparent. These studies have turned
out to be very effective in addressing key questions in human
biology, ranging from the genetics of social behaviour, and nature
versus nurture dilemmas, to the heritability of phenotypic variation
and disorders [9,30,31,32]. More recently, DNA methylation levels
have also become an important research topic in twins
[33,34,35,36,37,38]. In this report, we studied mono- (MZ) and
dizygotic (DZ) twins to address the fundamental question of the
impact of the genome on the degree of variation of the epigenome
by surveying the DNA methylation levels in the imprinting control
regions H19-ICR, IGF2-DMR, KvDMR and NESPAS-ICR and in
the sporadically methylated RUNX1/AML1 promoter, as examples
of genes exquisitely controlled by DNAmethylation. Using genomic
DNA from whole blood we interrogated the DNA methylation
levels at 83 CpG sites present in five regions in 256 healthy
adolescent twins pairs, using a highly sensitive and quantitative mass
spectrometric approach [22].
We show that even inMZ twins, a considerable degree of variability
exists in DNA methylation patterns, and we propose that this may
impact on variability in gene expression and possible differences in
disease susceptibility. Indeed, it has been shown that deregulation of
Table 1. Loss or gain of methylation (LOM or GOM, respectively: .10% difference from median).
H19-ICR (%) IGF2-DMR (%) KvDMR (%) NESPAS-ICR (%) RUNX1 (%)
MZ concordant for LOM 60 (2.0) 74 (4.3) 0 (0.0) 22 (0.8) 56 (1.8)
discordant for LOM 265 (9.0) 192 (11.1) 52 (1.9) 17 (0.6) 72 (2.3)
no LOM 2612 (88.9) 1464 (84.6) 2672 (98.1) 2720 (98.6) 3047 (96.0)
DZ concordant for LOM 38 (1.3) 60 (3.5) 0 (0.0) 0 (0.0) 56 (1.7)
discordant for LOM 268 (9.0) 195 (11.4) 20 (0.7) 17 (0.6) 72 (2.2)
no LOM 2665 (89.7) 1459 (85.1) 2735 (99.3) 2732 (99.4) 3106 (96.0)
chi-square test LOM P,0.01 ns P,0.001 P,0.001 ns
MZ concordant for GOM 110 (3.7%) 24 (1.4%) 0 (0.0%) 0 (0.0%) 4 (0.1%)
discordant for GOM 329 (11.2%) 174 (10.1%) 30 (1.1%) 32 (1.2%) 85 (2.7%)
no GOM 2498 (85.1%) 1532 (88.6%) 2694 (98.9%) 2727 (98.8%) 3086 (97.2%)
DZ concordant for GOM 110 (3.7%) 24 (1.4%) 0 (0.0%) 0 (0.0%) 4 (0.1%)
discordant for GOM 329 (11.1%) 174 (10.2%) 22 (0.8%) 32 (1.2%) 85 (2.6%)
no GOM 2532 (85.2%) 1516 (88.4%) 2733 (99.2%) 2717 (98.8%) 3145 (97.2%)
chi-square test GOM ns ns ns ns ns
Number (and percentage) of observations are displayed in the relevant groups. The chi-square test (362; df = 2) was performed to test for significant differences
between MZ and DZ twins (see Table S2 for other cut-off values for loss or gain of methylation).
doi:10.1371/journal.pone.0025590.t001
Impact of the Genome on the Epigenome Twin Study
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e25590
the imprinting status is linked to a number of disorders [9,11,12,13,
14,17,23,27,28,29,39]. Conversely, the observed variability could
imply that the DNA methylation levels at these positions in the
genome are less critical in blood cells or in adolescent life.
The intra-twin discordance analysis revealed MZ twins display
more similar DNA methylation levels in H19-ICR and the RUNX1
promoter compared to DZ twins or non-related individuals. Overall,
strong correlations in DNAmethylation were observed between CpG
sites of the same region. Similar CpG site-to-site dependencies in
DNA methylation patterns have been suggested previously [40,41].
These data support the key role of the (local) genetic sequence or
genomic context in the regulation of DNA methylation levels
[33,34,36,38]. Interestingly, the observed correlations did not extend
into other regions, not even between the closely related IGF2-DMR
andH19-ICR, which are part of the same imprinting locus with DNA
methylation marks present on the same parental allele. This is in
contrast to patients with Beckwith-Wiedemann or Silver-Russell
syndrome where both the H19-ICR and IGF2-DMR display a gain
or loss of methylation, respectively [42]. The independent behaviour
of the regions tested suggests no major global, chromosomal or
parental regulation of DNA methylation levels.
Interestingly, the analysis of gains or losses in DNA methylation
revealed frequent concordant losses inH19-ICR and NESPAS-ICR in
both individuals of an MZ twin pair, more frequent than in DZ twin
pairs, although some discordance in MZ twins was also observed for
KvDMR. The concordant deregulation further implicates a genetic
component to be involved in controlling the DNA methylation levels
in these regions. Still, most cases of deregulation (loss or gain) of DNA
methylation are found to be discordant, affecting only one individual
of a twin pair. Typically, these aberrations in the fine control of DNA
methylation levels can occur at the local or regional level, or even
across chromosomes, in trans. In about 15% of individuals tested the
IGF2-DMR displayed a loss of methylation (LOM), compared to
11% with a gain in DNA methylation (GOM). A previous study
reported about 10% of healthy individuals to display LOM and
proposed that this may be a predictive marker of risk for developing
colorectal cancer (CRC) [9]. To date, no cases of CRC are known
within our adolescent twin cohort.
Figure 5. Examples of monozygotic twin pairs with aberrant DNA methylation levels. Typical examples are shown of monozygotic twin
pairs harbouring gains or losses in DNA methylation levels relative to the median (m), highlighted in grey. The gains or losses - either concordant or
discordant - can be observed within the twin pairs and the aberrations can be local (only one chromosomal region), regional (nearby regions in the
genome) or even across different chromosomes (in trans). Y-axis shows the DNA methylation difference from the median (m). Colour legends and
locus info are shown below the graphs.
doi:10.1371/journal.pone.0025590.g005
Impact of the Genome on the Epigenome Twin Study
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e25590
Finally, the analysis of single nucleotide polymorphisms near the
interrogated imprinting control regions yielded compelling
evidence for a genetic impact on DNA methylation levels at
imprinted regions. In the IGF2/H19 domain, a striking correlation
was found between the maternal rs10732516 [A/G] polymor-
phism - as well as the co-inherited rs2839701 [G/C] polymor-
phism - and the DNA methylation state of the H19-ICR locus,
where both the maternal rs10732516 [A] allele and rs2839701 [G]
allele are linked to a hypermethylated state. The maternal H19-
ICR allele is generally unmethylated allowing CTCF to bind to its
seven binding sites in the region. However, the presence of the
rs10732516 [A] allele changes the sixth CTCF binding site in the
region, which, according to Takai et al [23], is the key CTCF
binding site regulating the expression of IGF2. In humans, it has
Figure 7. Clonal bisulphite sequencing of H19-ICR in individuals with different rs10732516 genotypes. The DNA methylation levels in
four samples with different rs10732516 genotypes were further investigated via clonal bisulphite sequencing. (A) MassCleave data for H19-ICR of the
four genotypes. (B) Clonal bisulphite sequencing analysis of the samples confirmed the genotype of the rs10732516 polymorphism (the [A] allele
highlighted in red). In addition, the hypermethylated state of the maternal rs10732516 [A] allele was confirmed. The maternal [A] allele in the [AA]
and [GA] individuals displayed higher methylation levels at the 59-end of the H19-ICR than the maternal [G] allele in [AG] or [GG] individuals (44% and
33% versus 16% and 20%, respectively; boxed regions).
doi:10.1371/journal.pone.0025590.g007
Figure 6. Influence of rs10732516 and rs2839701 on the DNA methylation levels in the H19-ICR region. (A) DNA methylation results are
sorted on the rs10732516 genotype, where the parent of origin is also taken into account. The rs10732516 [AA] and [GA] genotypes ([=R]) display
elevated DNA methylation levels compared to [AG] and [GG] genotypes. These differences in DNA methylation are visible throughout the H19-ICR
locus but are most apparent for CpG sites 2, 3 and 4. (B) Similarly, DNA methylation results are sorted based on the rs2839701 genotype. For CpG sites
2, 3 and 4 in the H19-ICR region, the rs2839701 [G] allele is associated with a higher DNA methylation compared to the [C] allele. These results show
that both polymorphisms within the IGF2/H19 region may predict or influence the DNA methylation status in individuals. Significant differences
between groups were identified using the non-parametric Kruskal-Wallis test, followed by a Dunn’s multiple comparison test (*: P-value,0.05;
**: P-value,0.01; ***: P-value,0.001).
doi:10.1371/journal.pone.0025590.g006
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been demonstrated that loss of differential methylation at this site
correlates with loss of imprinting (LOI) in Wilms’ tumours [27],
bladder cancer [23], colon cancer [28,29] and osteosarcoma [39].
Our detailed DNA methylation data of this region combined with
the reinterpretation of results of genome-wide CTCF binding
studies [25] suggests that the rs10732516 [A/G] polymorphism
may directly affect the binding affinity of CTCF to its target
sequence. This may also implicate a functional link between the
maternal rs10732516 and the methylation status of the (maternal)
allele. Future experiments should yield more insight into the
functional link between the SNP or local genotype and the
deregulated DNA methylation levels. Interestingly, it is not the
CpG sites immediately adjacent to rs10732516 that display the
most aberrant DNA methylation state. The CpG site with the
strongest deregulation is located 195 base pairs (or 15 CpG sites)
upstream of the SNP, proximal to the H19 gene. To exclude the
possibility of bias in our data introduced by genomic polymor-
phisms or mutations within the primer binding sequences, DNA
sequencing analysis of all interrogated regions were performed. No
mutations or genomic events were observed that could account for
a bias in the DNA methylation assays. To our knowledge, this is
the first time a single nucleotide polymorphism is associated with
parental specific methylation differences in the IGF2/H19 locus.
For the RUNX1 promoter, the local genotype near the RUNX1
gene may also be involved in the methylation discordance
observed in DZ twin pairs and between non-related individuals.
Further research will be necessary to resolve this question.
In conclusion, we have shown that a considerable degree of
variation in the DNA methylation at critically important regions in
the genome exists, even in genetically identical individuals, and we
have identified a clear example of the impact of the underlying
genetic sequence on potential perturbations of the epigenome.
Supporting Information
Figure S1 Details of interrogated CpG sites and re-
gions. Chromosomal coordinates and fragmentation patterns are
given for each assay. Above each graph the numbering of the CpG
sites is shown and below each graph the names of the interrogated
fragments are given between brackets. Interrogated and not-
interrogated CpG sites are shown as red and grey dots,
respectively. The CpG site containing rs10732516 [A/G] is
shown in blue, while the rs45596642 [A/T] is highlighted in
green. The vertical black lines in the graphs represent RNase A
cleavage sites. Figures have been generated using the ampliconRe-
port R-script [22].
(EPS)
Figure S2 Intra-twin discordance in DNA methylation
in H19-ICR per CpG unit. The discordance in DNA
methylation levels was calculated within MZ twin pairs, DZ twin
pairs and between non-related individuals (MZ, DZ and NR,
respectively). Significant differences between groups were identified
using the non-parametric Kruskal-Wallis test, followed by a Dunn’s
multiple comparison test (*: P-value,0.05; **: P-value,0.01).
(EPS)
Figure 8. Putative functional implication of rs10732516 on
CTCF binding in the H19-ICR region. (A) The Position Weight Matrix
(PWM) of the CTCF consensus sequence as determined by Cuddapah et
al. (2009) [44] harbours a strong preference for a cytosine residue at
position 6 of the PWM. Within the region upstream the H19 gene, this
cytosine is present in CTCF binding site numbers 4 and 6 (for the
rs10732516 [G] allele) [45]. The CTCF binding site number 5 within the
H19 region harbours a thymidine at position 6, and is identical in
sequence to CTCF binding site number 6 for the rs10732516 [A] allele
(CTCF sequences are on the minus strand). (B) Analysis of CTCF binding
at the H19 promoter region covering CTCF binding sites 4, 5 and 6 in six
normal cell lines identified site number 5 to have minimal binding
affinity within the region (ChIP-seq data from the ENCODE Chromatin
Group at the Broad Institute [25]; UCSC Genome Browser; HMEC: human
mammary epithelial cells; HSMM: normal human skeletal muscle
myoblasts; HUVEC: human umbilical vein endothelial cells; NHEK:
normal human epidermal keratinocytes; NHLF: normal human lung
fibroblasts; H1ES: human embryonic stem cell line H1). (C) Effect of
cytosine versus thymidine at position 6 of the PWM on the average
enrichment score near CTCF sites within the genome of HMEC cells.
Positions matching the PWM with 80% or greater sequence identity
were identified and the average enrichment scores near these sites
were determined 2500 to +500 base pairs relative to the CTCF motif.
Results for the other cell lines can be found as Figure S8. These
combined results suggest a strong influence of the rs10732516
genotype on the binding affinity of CTCF at this position in the H19-ICR.
doi:10.1371/journal.pone.0025590.g008
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Figure S3 Intra-twin discordance in DNA methylation
in IGF2-DMR per CpG unit. The discordance in DNA
methylation levels was calculated within MZ twin pairs, DZ twin
pairs and between non-related individuals (MZ, DZ and NR,
respectively). Significant differences between groups were identified
using the non-parametric Kruskal-Wallis test, followed by a Dunn’s
multiple comparison test (*: P-value,0.05; **: P-value,0.01).
(EPS)
Figure S4 Intra-twin discordance in DNA methylation
in KvDMR per CpG unit. The discordance in DNA
methylation levels was calculated within MZ twin pairs, DZ twin
pairs and between non-related individuals (MZ, DZ and NR,
respectively). Significant differences between groups were identified
using the non-parametric Kruskal-Wallis test, followed by a Dunn’s
multiple comparison test (*: P-value,0.05; **: P-value,0.01).
(EPS)
Figure S5 Intra-twin discordance in DNA methylation
in NESPAS-DMR per CpG unit. The discordance in DNA
methylation levels was calculated within MZ twin pairs, DZ twin
pairs and between non-related individuals (MZ, DZ and NR,
respectively). Significant differences between groups were identified
using the non-parametric Kruskal-Wallis test, followed by a Dunn’s
multiple comparison test (*: P-value,0.05; **: P-value,0.01).
(EPS)
Figure S6 Intra-twin discordance in DNA methylation
in the RUNX1 promoter per CpG unit. The discordance in
DNA methylation levels was calculated within MZ twin pairs, DZ
twin pairs and between non-related individuals (MZ, DZ and NR,
respectively). Significant differences between groups were identified
using the non-parametric Kruskal-Wallis test, followed by a Dunn’s
multiple comparison test (*: P-value,0.05; **: P-value,0.01).
(EPS)
Figure S7 Simultaneous SNP genotyping and analysis of
the allele-specific methylation status from MassCleave
spectra. Detailed example of four different genotypes analyzed
for the DNA methylation status of H19-ICR. The SNP status for
rs10732516 could easily be determined, as this polymorphism
changes the positions of spectral peaks. The peaks that change also
contain a number of CpG sites, so the methylation status associated
with the polymorphism could be deduced simultaneously. The
unmethylated rs10732516 [G] allele is visible as a peak at
5352.40 Da, while the methylated rs10732516 [G] allele forms a
peak at 5416.40 Da. *) The peaks for the rs10732516 [A] allele
(2878.82 and 2894.82 Da) overlap with peaks of another fragment
of H19-ICR (CpG7) resulting in more subtle spectral changes at
these positions. As the [A] allele has introduced a novel cleavage site
for the RNase A, only one CpG site is associated with this SNP. The
grey crossed-out circles indicate CpG sites not interrogated in the
assay. Figure was adapted from Coolen, et al. (2007) [22].
(EPS)
Figure S8 Effect of cytosine versus thymidine at posi-
tion 6 of the Position Weight Matrix (PWM) for CTCF
binding sites on the average enrichment score near
CTCF motifs within the genome of six normal cell lines.
Positions matching the PWM with 80% or greater sequence
identity were identified and the average enrichment scores near
these sites were determined 2500 to +500 base pairs relative to
the CTCF motif. The mean enrichment scores for the PWM
with a thymidine at position 6 are about half of the scores with a
cytosine at this position, in all cell lines tested (HMEC: human
mammary epithelial cells; HSMM: normal human skeletal
muscle myoblasts; HUVEC: human umbilical vein endothelial
cells; NHEK: normal human epidermal keratinocytes; NHLF:
normal human lung fibroblasts; H1ES: human embryonic stem
cell line H1).
(EPS)
Table S1 Primers and PCR conditions.
(PDF)
Table S2 Loss and gain of methylation in twins (various
cut-offs for difference from median).
(PDF)
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